Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Thailand, Bangkok
Clinic is certified :
Myeloma treatment cost in Thailand typically depends on the diagnostic intensity and chosen therapy protocols. Detailed evaluation often starts with a consultation with an oncohematologist ranging from $100 / ฿3,400 to $200 / ฿6,800, while essential biochemical blood analysis runs from $100 / ฿3,400 to $100 / ฿3,400. Total expenses vary by cancer stage and hospital type, often providing 50% to 80% savings compared to the United States. Bangkok remains the primary destination for specialized hematology care.
Typical Myeloma Treatment Costs in Thailand
Bookimed Expert Insight: Complex blood disorders require high-tech centers with international accreditation for the best outcomes. Bumrungrad International Hospital is a top-tier choice, holding JCI and GHA certifications while serving over one million patients annually. Patients seeking specialized hematology expertise can consult with doctors like Kodchanut Litleaungdej, a Thai Board-certified hematologist. For those interested in integrative approaches, Panacee Hospital Rama 2 offers cell therapy and holistic cellular-level healthcare.
| Thailand | Turkey | Austria | |
| Plasmapheresis | from $2,200 / ฿74,800 | from $1,200 / ฿40,800 | from $2,000 / ฿68,000 |
| Therapeutic Apheresis | - | from $1,350 / ฿45,900 | - |
| Plasma Exchange | - | from $3,900 / ฿132,600 | - |
| DFPP Plasmapheresis | - | from $1,850 / ฿62,900 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Myeloma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Myeloma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Myeloma treatment journey.
Pioneer hematologist at Huahin Hospital with a strong academic background in myeloma cases.
The doctor is an experienced oncologist and oncohematologist with a specialization in bone marrow transplants. They have dedicated their career to advancing treatments in oncology and hematology, focusing on innovative therapies and patient care. The doctor has contributed significantly to clinical research in their field, enhancing treatment protocols and improving patient outcomes. Their work in bone marrow transplantation is particularly notable, with a track record of successful procedures and improved survival rates for patients.
Thai hospitals are fully equipped for advanced Multiple Myeloma through JCI-accredited centers in Bangkok. They offer autologous stem cell transplants and targeted therapies using immunomodulatory drugs. Facilities like Bumrungrad International Hospital utilize AI-driven diagnostics and digital imaging to manage complex hematological cases effectively.
Bookimed Expert Insight: Thai medical infrastructure shows a clear divide between general care and oncology. Bumrungrad International Hospital serves over 1,000,000 patients annually with a 50% international demographic. This high volume across 70 departments ensures that myeloma patients with kidney or bone complications receive immediate subspecialty consultation in one building.
Patient Consensus: Patients note that large private hospitals in Bangkok provide exceptionally fast lab results and specialist access. They emphasize having all pathology reports translated before arrival to streamline the transition to local maintenance therapy.
Autologous Stem Cell Transplant (ASCT) is widely available in Thailand at JCI-accredited facilities and specialized oncology centers. Medical centers in Bangkok provide these procedures for myeloma using techniques like peripheral blood stem cell therapy. Outcomes are comparable to Western standards in major hospitals.
Bookimed Expert Insight: Thailand is a hub for high-volume care, with Bumrungrad International Hospital alone serving 1,000,000+ patients annually. Our data shows that 50% of their patients are international. This high volume across 70 departments ensures that specialist infrastructure like ICU backup is always ready. Patients seeking ASCT should prioritize these massive centers over smaller regenerative clinics. This ensures access to essential infection-control support and high-dose conditioning facilities.
Patient Consensus: Patients note it is critical to distinguish between professional hematology-oncology transplant units and general regenerative clinics. Many emphasize that confirming bed availability and an English-speaking coordinator is essential before traveling.
Patients can access advanced myeloma drugs like Daratumumab and Lenalidomide in Thailand. Leading JCI-accredited hospitals in Bangkok stock these monoclonal antibodies and immunomodulators. Specialized hematologists use them in standard front-line regimens. Verification of current pharmacy stock is necessary before arrival.
Bookimed Expert Insight: Thailand ranks 7th globally in our medical tourism data for complex care. While these drugs are available, access is highly location-dependent. High-volume centers like Bumrungrad serve 1,000,000 patients annually and maintain international drug procurement channels. Smaller clinics may not stock these high-cost oncology medications routinely.
Patient Consensus: Patients note that even when drugs are available, the exact brand or formulation may differ from home. Many recommend coordinating with a hematologist early to confirm insurance coverage or import requirements.
You do not need to stay in Thailand for your entire myeloma treatment. Most protocols are phase-based and allow for travel between induction and maintenance stages. Thai medical visas offer flexible stays of 60 to 180 days to accommodate these treatment cycles.
Bookimed Expert Insight: Thai oncology centers like JCI-accredited Bumrungrad International Hospital serve over 500,000 international patients annually. Their high volume means they have streamlined protocols for sharing bone marrow and cytogenetics reports with home-country doctors. This coordination ensures you can safely pause your stay in Bangkok during maintenance phases without losing treatment continuity.
Patient Consensus: Patients note that staying for the full duration is often physically and financially unrealistic. They emphasize keeping physical copies of all lab trends to make traveling between cycles much safer.
Clinical trials for relapsed/refractory myeloma are available at leading medical centers. These trials provide access to advanced treatments like CAR T-cell therapy and bispecific antibodies. Specialized protocols focus on overcoming drug resistance and improving survival for patients who have completed multiple therapy lines.
Bookimed Expert Insight: While many seek clinical trials for new drugs, the most valuable options in Bangkok often involve optimized sequencing. Data from major institutions like Bumrungrad International Hospital shows that combining established therapies with advanced apheresis can stabilize patients between trial phases. If a trial requires frequent visits, choosing an integrated hospital with 600+ beds ensures all supportive care stays under one roof.
Patient Consensus: Patients note that major hospitals in Bangkok are much more likely to have open trials than community clinics. It is a good idea to bring a full treatment history including every drug regimen and relapse date to your first meeting.
Thailand private hospitals offer nearly zero wait times for cancer care. Urgent surgical cases generally receive treatment within 10 days. Most private centers in Bangkok schedule consultations within days. This contrast sharply with public hospitals where 25% of patients wait over 30 days.
Bookimed Expert Insight: While public systems face delays, private hospitals like Bumrungrad International Hospital manage 1 million patients annually with high efficiency. Data shows these centers prioritize international patients who make up 50% of their volume. Choosing JCI-accredited facilities ensures Western-standard protocols without the months-long queues common in public universal coverage schemes.
Patient Consensus: Patients note that while appointments happen quickly, completing specialized tests like marrow biopsies takes time. They emphasize having funds or insurance ready to avoid financial clearance delays before starting treatment.
Choose a specialist by verifying certifications from the Thai Board of Hematology and experience in oncohematology. Prioritize doctors at JCI-accredited facilities in Bangkok like Bumrungrad International Hospital. These experts manage complex myeloma cases using advanced diagnostic methods like biochemical blood analysis and bone marrow consultations.
Bookimed Expert Insight: Thailand's medical landscape features distinct specialization hubs. While large centers like Bumrungrad International Hospital serve over 1,000,000 patients annually with massive infrastructure, smaller clinics often focus on regenerative medicine. If your myeloma treatment requires stem cell support, look for facilities with ISO 9001:2015 quality certifications that specialize in GMP-certified cell rejuvenation.
Patient Consensus: Patients emphasize finding a doctor who explains tailored treatment plans clearly. They also recommend verifying that the physician works at a top-tier hospital recognized for oncology.
Thailand offers multiple myeloma treatment comparable to Western countries. Top hospitals like Bumrungrad International hold Joint Commission International (JCI) accreditation. They provide advanced care including stem cell therapy and specialised haematology consultations. Outcomes and technology match Western standards at significantly lower costs.
Bookimed Expert Insight: Thailand’s major hospitals treat nearly 1,000,000 patients annually, showing high capacity. Bumrungrad International features 1,300 doctors across 70 departments, reflecting diverse expertise. Panacee Hospital Rama 2 combines regenerative and chronic disease treatments, welcoming integrative therapies alongside standard myeloma care.
Patient Consensus: Patients appreciate clear symptom relief and friendly care in Thailand. Australians highlight effective radiation and pain management, plus helpful English support. Some note stem cell therapy results vary, so managing expectations about experimental treatments matters.
Common multiple myeloma treatments in Thailand include stem cell transplants, targeted drugs, chemotherapy, and radiation. Leading hospitals use immunomodulatory drugs like lenalidomide and proteasome inhibitors such as bortezomib. Stem cell transplantation follows induction therapy for eligible patients, improving long-term control.
Bookimed Expert Insight: Stem cell transplant remains key but some patients avoid it due to isolation and language concerns. Bumrungrad International Hospital in Bangkok has advanced equipment and English-speaking staff, easing treatment for Australians. Experimental regenerative therapies exist but lack robust proof, so standard drug and transplant combos remain the go-to approach.
Patient Consensus: Patients in Thailand note pain relief often comes after a few chemo cycles with drugs like Velcade. Isolation during stem cell transplant is tough but manageable with English support. Radiation helps with bone pain, letting patients stay mobile during treatment.
Autologous stem cell transplants for multiple myeloma in Thailand follow global protocols. Patients undergo stem cell collection, high-dose chemotherapy, then stem cell reinfusion. Leading centres include Bumrungrad International Hospital, which offers JCI accreditation and English-speaking staff. Panacee Hospital Rama 2 provides regenerative cell therapy but is not a standard myeloma transplant centre.
Bookimed Expert Insight: Thailand's top transplant centre, Bumrungrad, combines JCI accreditation with telemedicine and English interpreters. This makes care accessible and safer for international patients. Meanwhile, some regenerative clinics promoting stem cell therapies for myeloma are not evidence-based and have faced legal issues. Australians should prioritise hospitals with proven international protocols.
Patient Consensus: Patients note Thailand offers skilled specialists and clear communication in English. Many stress the importance of proper hospital accreditation and warn about confusing regenerative clinics with standard transplants. Those who used recognised transplant centres highlight good hospital care and infection safety.
Advanced diagnostic tests for multiple myeloma are available in Thailand, especially in Bangkok. Leading hospitals offer blood tests, bone marrow biopsy, and imaging like PET/CT and MRI. Genetic testing such as FISH is accessible to help guide treatment.
Bookimed Expert Insight: Thailand’s top hospitals combine global-standard diagnostics with integrative therapies. Panacee Hospital Rama 2 offers cell therapies alongside diagnostics, while Bumrungrad handles over 1 million patients yearly, providing robust imaging and genetic tests. Australians should bring their previous results to avoid repeat tests.
Patient Consensus: Patients note that Thai hospitals follow international myeloma diagnostic steps, including comprehensive imaging and biopsies. They advise confirming availability of advanced genetic tests before travel. Many appreciate combining diagnostics with targeted treatments at private Bangkok clinics.
Top multiple myeloma specialists in Bangkok are at Bumrungrad International Hospital and Panacee Hospital Rama 2. Bumrungrad is JCI-accredited, sees over 1 million patients yearly, and offers expert haematology and oncology care. Panacee combines cell therapy with regenerative medicine.
Bookimed Expert Insight: Bumrungrad International leverages its large patient volume and global accreditations to serve Australians well. Panacee Hospital offers complementary cell therapy options rarely found in standard myeloma care. Australians benefit from Bumrungrad's English-speaking staff and direct insurance billing, easing treatment logistics.
Patient Consensus: Patients highlight Bangkok Hospital group’s top myeloma care and advanced tech like proton therapy. Many value private centres’ English support, but recommend arranging translation for smaller hospitals. Siriraj Hospital doctors set high standards and often work with private clinics for best care.
International patients can access multiple myeloma treatment easily in Thailand, especially at JCI-accredited hospitals like Bumrungrad International. These hospitals offer advanced therapies including stem cell transplants and have English-speaking staff. Thailand’s medical tourism infrastructure supports international patients well.
Bookimed Expert Insight: Thailand’s top hospitals like Bumrungrad excel in serving international patients with multiple myeloma. Their large patient volumes and international accreditations mean smoother processes and expert care. Though stem cell transplant protocols include isolation phases, familiar hospitals offer better support and interpreter services.
Patient Consensus: Patients note Thailand’s big hospitals ease language and logistics challenges. Bringing translated medical records is vital to avoid delays. The medical visa options suit multi-step treatments, and the care feels well organised for international travellers.